Michael Landsittel - Net Worth and Insider Trading
Michael Landsittel Net Worth
The estimated net worth of Michael Landsittel is at least $6 Million dollars as of 2024-11-05. Michael Landsittel is the CHIEF FINANCIAL OFFICER of Blueprint Medicines Corp and owns about 67,208 shares of Blueprint Medicines Corp (BPMC) stock worth over $6 Million. Details can be seen in Michael Landsittel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Landsittel has not made any transactions after 2024-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Landsittel
Michael Landsittel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Landsittel owns 1 companies in total, including Blueprint Medicines Corp (BPMC) .
Click here to see the complete history of Michael Landsittel’s form 4 insider trades.
Insider Ownership Summary of Michael Landsittel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-08-15 | Principal FAO |
Michael Landsittel Latest Holdings Summary
Michael Landsittel currently owns a total of 1 stock. Michael Landsittel owns 67,208 shares of Blueprint Medicines Corp (BPMC) as of August 15, 2024, with a value of $6 Million.
Latest Holdings of Michael Landsittel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-08-15 | 67,208 | 92.25 | 6,199,938 |
Holding Weightings of Michael Landsittel
Michael Landsittel Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Landsittel has made a total of 8 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 4,409 shares on August 15, 2024, which brought Michael Landsittel around $419,869.
Insider Trading History of Michael Landsittel
- 1
Michael Landsittel Trading Performance
Michael Landsittel Ownership Network
Ownership Network List of Michael Landsittel
Ownership Network Relation of Michael Landsittel
Michael Landsittel Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Michael Landsittel is the Principal FAO of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include President & R and D Fouad Namouni , director & CEO & President Jeffrey W. Albers , and Chief Commercial Officer Philina Lee .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Michael Landsittel made 5 insider transaction in Blueprint Medicines Corp (BPMC) with a net sale of 38,146. Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 14,415 shares made by Ariel Hurley , and a net sale of 9,342 shares made by Christopher K. Murray .
In summary, during the past 3 months, insiders sold 27,744 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 27,744 shares. During the past 18 months, 464,866 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 464,866 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Michael Landsittel Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Landsittel. You might contact Michael Landsittel via mailing address: Blueprint Medicines Corp., 214 First Street, Suite 340/350, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
